You had two questions. The first was about dealing with the Bush administration and others. Again, this legislation has nothing to do with generic companies providing medicines abroad that are not covered by patent. This legislation has nothing to do with brand-name companies providing their products, whether it's philanthropically or for sale, abroad. They can do that now.
This legislation is intended to allow generic companies to access patented medicines. I think we should stay focused on that. It's all very good that we have donation programs and the brands have donation programs. It has nothing to do with this legislation.
And as far as talking to the brand-name companies is concerned, I would say that their intention here is to ensure that the legislation protects the interests of brand-name companies, and it's not to ensure that generic companies are able to make copies of their patented products and ship them abroad.
So we have not had discussions with them.